Fred Witjes affirms what most of us believe: with update in #EAU21 Risk Stratification things are too complicated; the #AUA21 risk stratification is much easier/clinically relevant European Association of Urology (EAU) Amer. Urol. Assn. Sam S. Chang MD, MBA Marek Babjuk Maria J. Ribal james mckiernan Richard Sylvester #bladdercancer

Detailed analysis by Kelly Bree MD Anderson Cancer Center showing why recent update to #EAU21 risk classification for NMI #bladdercancer is not relevant for patients being treated with immunotherapy (which, in all fairness, they do admit!) #AUA21 Roger Li

T&TV61: Incision of infundibulum. If you cannot reach the stone (especially in the lower pole), while you are in maximum deflection: the infundibulum must then be incised. With a Thulium-Fiber laser: 1J-10Hz-ShortPulse (HPP-500W). Benefits: precision and bloodless

Avrasya Üroonkoloji Derneğimizin düzenlediği Kadavrada Laparoskopik Cerrahi kursunda kursiyerlerimizle beraber ileri laparoskopik ürolojik cerrahi eğitimindeyiz. Abdullah Erdem Canda Mehmet Fatih Akbulut #arifozkan Eurasian Uro-oncological Association RMK AIMES Koç University, Department of Urology, Istanbul

We wait all our fellow collegues to the below mentioned multiinstitutional Urologic Oncology tumor board. Selcuk Erdem İTF Üroloji A.D. Ürolojik Onkoloji Bilim Dalı Prof.Dr.Faruk Özcan Fulya Ağaoğlu Mehmet Fatih Akbulut Sorry for our international collegues, board language will be Turkish

We are thankful to our fellow collegues who attended to our online multiinstitutional tumor board. Over informative cases, amazing discussions were done. İTF Üroloji A.D. Ürolojik Onkoloji Bilim Dalı Prof. Dr. Uğur Boylu Esra Kaytan Saglam asifyildirim Mehmet Fatih Akbulut İ.Ü. İ.T.F. Üroloji Prof.Dr.Faruk Özcan Ugur Selek Prof. Dr. Murat Binbay

Partial cystectomy for bladder #Paraganglioma. Thanks to all team. (Endocrinology, Anesthesiology and Urology teams) #bladdercancer #partialcystectomy

"When MRI became available without any limitations in our region, the number of prostate biopsy sessions decreased by 20%, the numbers of significant tumors remained the same, and the number of insignificant cancers decreased by 48%." #UroSoMe ➡️ow.ly/bW2u50INYci

BWALE-33: The transparent tip of a Laser Fiber is very fragile. It can break. Use Nitinol basket to remove it. But remember that we dont need transparent tip. So CUT it with regular scissors. Laser efficiency remains the same,tip visibility is excellent(blue) &no risk of breakage

Let the debates start (again!) PHOTO: Randomized trial PDD-guided TURBT did not reduce recurrence rates, nor was it cost-effective compared with WL at 3 years NEJM Evidence Prof Param Mariappan FRCS(Urol), PhD Prof Emma Hall BAUS Sia Daneshmand, M.D. #bladdercancer evidence.nejm.org/doi/full/10.10…

BCG cheat sheet Bladder Cancer Advocacy Network for patients - includes schedule for patients to use/bring to their urologist's clinics for scheduling bcan.org/wp-content/upl… #bladdercancer #patientsafety #immunotherapy Stephanie Chisolm, PhD MD Anderson Cancer Center European Urology Oncology UroToday.com Janet Kukreja

We have 3000 lives passed away close to 20000 injured and many more in rubbles . Death toll is increasing. If you can encourage your communities for donation to Kızılay ( Turkish Red Crescent) and AFAD, We would be grateful☘️

𝗗𝗨𝗬𝗨𝗥𝗨 | Tüm vatandaşlarımızı kan bağışı merkezlerimize davet ediyoruz. 🩸⚠️ 🔗 kanver.org

DrBagrodia Sam S. Chang MD, MBA Eugene Pietzak Joshua Meeks Tim Clinton Sia Daneshmand, M.D. Solomon Woldu Sarah P. Psutka MD MS Max Kates Sima Porten Shahrokh F. Shariat Rich Matulewicz Risk adapted - would aim for minimum as follows: TaHG - iBCG x 6 + mBCG x 3 CIS - iBCG x 6 + mBCG x 3, 3, 3 T1HG - iBCG x 6 + mBCG x 3, 3, 3 - try for 3 yrs Dose reduction allows 3 patients per vial If can't give mBCG at all, would use Gem-Doce

Extended Lymph Node Removal Not Beneficial for Bladder Cancer - Renal and Urology News renalandurologynews.com/home/news/urol…

Our new study about HIVEC The efficacy of hyperthermic intravesical chemotherapy in high-risk non-muscle-invasive bladder cancer patients with BCG intolerance. Combat Medical #HIVEC #HIPEC #HIVEC #bladdercancer pubmed.ncbi.nlm.nih.gov/37470319/

Our new study has been published. #HIVEC thermochemotherapy vs BCG. Promising results Combat Medical #HIVEC #HIPEC

En bloc TURBT (for <1 cm tumors) results in Similar recurrence rates: 18.4% vs 16.7% at 1 yr Similar residual disease on reTUR 56% vs 55.9% (small subset) More retrieval of DM: 80.7% vs 71.1% Less bladder perforation: 5.6% vs 12% Similar OR time: 26 vs 25 min

Our study entitled ‘‘Performance of the EORTC and CUETO Models to Predict Recurrence and Progression in High-risk Non-muscle-invasive Bladder Cancer Patients’’ has just published. Ashish M. Kamat, MD, MBBS #bladdercancer pubmed.ncbi.nlm.nih.gov/38493314/

Sequential intravesical gemcitabine+ docetaxel combination in BCG Refractory patient. Patient’s feedback about the treatment process. Medipol Üniversitesi Medipol Bahçelievler Hastanesi instagram.com/reel/DBlnBnLtP…